By Angela Moon
NEW YORK (Reuters) - Stocks advanced on Monday after a rosy outlook from FEDEX (FDX.NY)nd strong home sales data fueled optimism, helping the S&P 500 stay above a key resistance level that could confirm Wall Street may be back in bullish mode.
Shares of economic bellwether FedEx Corp
A surprising 23.6 percent jump in new home sales in June from May offset some disappointing data in recent weeks that sparked fears that the economy may slip back into recession.
The "markets are focusing in on more recent data as hopefully being indicative of what's ahead," said Tim Ghriskey, chief investment officer at Solaris Asset Management in New York.
The Dow Jones industrial average <.DJI> added 56.54 points, or 0.54 percent, at 10,481.16. The Standard & Poor's 500 Index <.SPX> gained 8.36 points, or 0.76 percent, to 1,111.02. The Nasdaq Composite Index <.IXIC> rose 14.66 points, or 0.65 percent, to 2,284.13.
The S&P 500 held above the 1,100 level after closing just above that level on Friday, which can be seen as significant since it "breaks the bulk of the top end of the trading range for the last several months," according to Bryan McCormick, options strategist at optionMonster.com.
At midday, both the Dow and the Nasdaq were slightly higher for the year to date, while the S&P 500 was within just a few points of break-even following declines from the late April closing highs due to anxiety about the euro zone's debt troubles and the high U.S. unemployment rate.
"The big question now is whether the rally has exhausted itself in making the move to resistance ... A strong breakout now would go a long way toward confirming that the index is truly back on a bullish track. A failure would be equally frustrating and would likely see us lapse back into the existing trading range awaiting a stronger catalyst," he said.
He noted that the S&P 500's next big resistance level is at the 200-day moving average, at 1,114.21.
The S&P 500 rose 7.8 percent during the three weeks ended Friday, the largest gain in such a period since the first week of August 2009.
Home building products manufacturer Masco Corp
Genzyme Corp
Genzyme shot up 6.9 percent to $66.81.
Sources familiar with the matter said on Friday that Sanofi-Aventis
BP Plc
U.S.-traded shares of BP
(Reporting by Angela Moon; Editing by Jan Paschal)